BioMedWorks’ Newsletter

BioMedWorks’ Newsletter

Share this post

BioMedWorks’ Newsletter
BioMedWorks’ Newsletter
Liver Learnings: New News on NASH

Liver Learnings: New News on NASH

Vitamins are vital and thyroid hormones, too. PREMIUM CONTENT subscriber access.

BioMedWorks's avatar
BioMedWorks
Aug 21, 2022
∙ Paid
2

Share this post

BioMedWorks’ Newsletter
BioMedWorks’ Newsletter
Liver Learnings: New News on NASH
1
Share
Development of NASH from healthy liver. https://www.creative-biolabs.com/nash-therapy/drug-discovery-for-nash-treatment.htm

In a prior newsletter, I reported on breakthrough treatment news for Interstitial Pulmonary Fibrosis. Metformin, thiamine and thyroid hormones all showed beneficial effects as modalities. Now we see progress in the hepatic fibrosis sphere, also by using vitamins and thyroid hormone analogues.

The substrate-overload liver injury model of NASH pathogenesis. (Friedman, 2018). Friedman, S.L.; et al. Mechanisms of NAFLD development and therapeutic strategies. Nature medicine. 2018: 1.

The pathophysiology of NASH is complex and includes multiple parallel hits. NASH is characterized by steatosis as well as hepatocyte injury and inflammation, with or without fibrosis.

BioMedWorks’ Newsletter is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber.

Keep reading with a 7-day free trial

Subscribe to BioMedWorks’ Newsletter to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 BioMedWorks LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share